Palisade Bio (PALI) Operating Leases (2019 - 2024)
Palisade Bio (PALI) reported Operating Leases of $24000.0 for Q2 2024, down 84.31% year-over-year from $153000.0 in Q3 2023, and down 58.62% quarter-over-quarter from $58000.0 in Q1 2024.
Palisade Bio (PALI) Operating Leases (2019 - 2024) Analysis & Trends
Palisade Bio (PALI) has 6 years of Operating Leases data on file, last reported at $24000.0 in Q2 2024.
- Operating Leases for Q2 2024 came in at $24000.0, down 84.31% year-over-year; the trailing twelve-month figure through Jun 2024 was $24000.0 (down 84.31% YoY), and the FY2023 annual result was $90000.0, down 57.35% from the prior year.
- Operating Leases fell to $24000.0 in Q2 2024 per PALI's latest filing, from $58000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $364000.0 in Q2 2022 and troughed at $17000.0 in Q2 2021.
- A 5-year average of $143637.7 and a median of $136395.0 in 2020 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2021 and 2022: Operating Leases tumbled 86.8% in 2021, then surged 2041.18% in 2022.
- A 5-year view of Operating Leases shows it stood at $112000.0 in 2020, then surged by 41.07% to $158000.0 in 2021, then jumped by 33.54% to $211000.0 in 2022, then tumbled by 57.35% to $90000.0 in 2023, then tumbled by 73.33% to $24000.0 in 2024.
- Business Quant data shows PALI's Operating Leases at $24000.0 in Q2 2024, $58000.0 in Q1 2024, and $90000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 24,000.00 |
| Mar 31, 2024 | 58,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Sep 30, 2023 | 122,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Mar 31, 2023 | 182,000.00 |
| Dec 31, 2022 | 211,000.00 |
| Sep 30, 2022 | 239,000.00 |
| Jun 30, 2022 | 364,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 17,000.00 |
| Dec 31, 2020 | 112,000.00 |
| Sep 30, 2020 | 159,400.00 |
| Jun 30, 2020 | 128,770.00 |
| Mar 31, 2020 | 136,395.00 |
| Dec 31, 2019 | 148,543.00 |
| Sep 30, 2019 | 183,520.00 |